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Thepresentstudy. The report by O’licefee ill. (II I” thl\ 
issue of the Journal appears at a tune when tb,re i\ mtenx 
interest in a candid evalualion of the long-tern rcsol~\ of 
percutaneous coronary angioplasly. In their study one is 
impressed with both the fxedom from ;mgiopla\ty cumph- 
cations and the unavoidable temptation to compare dw\i: 
resolts with surgery. However, B number of que~twnr are 
suggested by this excellent study. 
A resrenosis mole in this cohorr u/po~uwr of odr IX”; 
appears wvealisricully low. This figure IS probabl) the most 
favorable yet reported and does not appear commeo,uro,e 
with most previously published data. The low rate may be 
explained by the fact that another separate ubgroup (I?% of 
the total patients studied. described as having restenosis and 
disease progression a! new sites) WBE established and it may 
be that some of the patients in whom angioplasty for 
restenosis failed are hidden in this group. Even if the latter 
patients were combined with those who definitely had re- 
stenosis. the investigation would Ml be laudable. 
Coronary attery versus vein graft angiographie SUPCW. A 
seenndquestioncooceros the angiograpbic success rate after 
percutaneous dilation of saphenous vein bypass grafts. The 
authors equate a 97% angiographic success rate in the 
proximal and mid-left anterior descending coronary artery 
with obstructive lesions of the saphenoos vein graflr. Thin is 
somewhat misleading because earlier studies have demon- 
strated the I yearrestenosis rate to bediticrcm in the various 
segments of vein grafts. For instance. in the proximal vein 
graft the rate of restenosis at 6 months to a year (hardly il 
long-term follow-up) is approximately 7% in the mid- 
saphenous vein graft this rate is 64% and at the dktal 
anastomolic site (the most favorable) the restenosi‘; rate is 
candidarc\ for angioplasty and physiologically were very 
w~dar to pilticnts “,th double vessel discase. This fxtor i\ 
con&lent Glh the excellent early and late results of Ihe 
:wlhor>’ \tady 111 It could alw tyiplain any difference in 
re’uIl\ bcr\\ccn patients who have had dng,oolarry and those 
\bho have hod coronary bypar\ ru,gery and aould be f,n!,er 
cwdcncc lhat l&y angiuplaity sod surgical cohorts of 
pnt~nr~ reprc\wd enrirely diffwnt groups. In rhn serier 
only IO5 of patients had an ejection fraction 540%. thus 
drscnbmg a group al errrcmcly good nrk m terms of 
revarcul~ri~alwn. As the authors attest. no attempt should 
be made IO compare surgical and angmplanty pat/entc m a 
nonr:mdomued study such as thcirr. 
Conclosions. Bscause the results are rather exceptional. 
the reader wonders about Ihc imolrarions for hiah risk 
coronary angioplasty patients. Sye&ally, what & the 
mansgemem crileria for pnlientc with total occlusion of one 
or more coronary oncries. with akincsia of a major cardiac 
region with a culprit lesion in an artery supplying another 
nwa. wtrh diffux disease in one or more coronary anerie% 
wth diat,d wronary arteries that perfuse poorly even though 
the proGoal obstruction is successfully dilated and finally. 
with diffuse multivessel disease and ischemic mitral regurgi- 
tahon’! The authors have presented a “clean” populatton of 
palirntr id very low risk and this fact muhf be emphasized. 
In spite ofthrconcerns I have about Ihe precise definition 
of p:tlicnt wbgroups included in the study. the authors are IO 
be commended on an outsundiog investigadon with ercel- 
lent clinicill results. 
